Cargando…

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?

BACKGROUND: Although bisphosphonate is effective for the prevention and treatment of osteoporosis, poor medication compliance is a key-limiting factor. We determined whether alarm clock could improve compliance with weekly bisphosphonate in patients with osteoporosis, by comparing with age- and gend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nho, Jae-Hwi, Lee, Young-Kyun, Ha, Yong-Chan, Kim, Chung-Hyun, Suh, You-Sung, Koo, Kyung-Hoi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Bone and Mineral Research 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900960/ https://www.ncbi.nlm.nih.gov/pubmed/27294076 http://dx.doi.org/10.11005/jbm.2016.23.2.51

Ejemplares similares

Which Bisphosphonate? It's the Compliance!: Decision Analysis
por: Lee, You Jin, et al.
Publicado: (2016)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Alarm Services as a Useful Tool for Diagnosis and Management of Osteoporosis in Patients with Hip Fractures: A Prospective Observational Multicenter Study
por: Ok, Hyun-Soo, et al.
Publicado: (2020)

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
por: Kishimoto, Hideaki, et al.
Publicado: (2015)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty: Good results in 19 patients followed for mean 4 years
por: Lee, Young-Kyun, et al.
Publicado: (2013)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

To withhold or to implement bisphosphonate after cementless hip arthroplasty: a dilemma in elderly hip fracture patients
por: Lee, Young-Kyun, et al.
Publicado: (2019)

Atypical incomplete femoral neck fracture in patients taking long-term bisphosphonate: Case report, a report of 2 cases
por: Suh, You-Sung, et al.
Publicado: (2019)

Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea
por: Lee, Young-Kyun, et al.
Publicado: (2018)

Knowledge on Osteoporosis among Nurses
por: Park, Chan-Ho, et al.
Publicado: (2017)

Low Positive Predictive Value of Bone Scan to Predict Impending Complete Fracture among Incomplete Atypical Femoral Fracture
por: Lee, Young-Kyun, et al.
Publicado: (2018)

National Trends of Surgical Treatment for Intertrochanteric Fractures in Korea
por: Lee, Young-Kyun, et al.
Publicado: (2013)

Knowledge on Osteoporosis of Prescriber According to Level of Medical Institute
por: Yoon, Byung-Ho, et al.
Publicado: (2014)

Orthopedic Surgeon's Awareness Can Improve Osteoporosis Treatment Following Hip Fracture: A Prospective Cohort Study
por: Kim, Sang-Rim, et al.
Publicado: (2011)

Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
por: Seno, Takahiro, et al.
Publicado: (2016)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Epidemiology of Osteoporosis and Osteoporotic Fractures in South Korea
por: Lee, Young-Kyun, et al.
Publicado: (2013)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Effect of Dosing Interval on Compliance of Osteoporosis Patients on Bisphosphonate Therapy: Observational Study Using Nationwide Insurance Claims Data
por: Lee, Hyunil, et al.
Publicado: (2021)

Osteoporosis and Osteoporotic Fracture Fact Sheet in Korea
por: Ahn, Seong Hee, et al.
Publicado: (2020)

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018)

Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern
por: Ko, Kyung Rae, et al.
Publicado: (2020)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates
por: Gu, Tao, et al.
Publicado: (2016)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Extensive Bullous Complication Associated with Intermittent Pneumatic Compression
por: Won, Sung-Hun, et al.
Publicado: (2013)

Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010)

Hip Fractures in Centenarians: Functional Outcomes, Mortality, and Risk Factors from a Multicenter Cohort Study
por: Jang, Byung-Woong, et al.
Publicado: (2023)

Compliance with Washington State's requirement for residential carbon monoxide alarms
por: Hampson, Neil B., et al.
Publicado: (2017)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial
por: Nanki, Toshihiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_elsbvleijbp8bf3lg183tu36n9